Pune, India -- (SBWire) -- 03/01/2018 --The Branded Generics Market accounted to USD 190.3 billion in 2016 growing at a CAGR of 7.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Also the Global Branded Generics Market By Formulation Type (Oral, Parental, Topical), By Therapeutic Application (Oncology, Cardiovascular, Diabetes, Neurology, Gastrointestinal, Dermatology, Analgesics and Anti-inflammatory), By Category (Simple Generics, Super Generics, Biosimilars), By Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Others) By End User (Hospital, Clinic, Ambulatory Center), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.
Branded generics are off-patent drugs are bioequivalent to the original product which are marketed under other company's brand name. the products offer value to patients and healthcare professionals preferring branded drugs.
Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-branded-generics-market
Major Market Drivers and Restraints:
- Government initiatives
- Increase in the number of patent expiration of branded drugs
- Increasing incidences of chronic diseases
- Limited availability of generic drugs
Branded Generics Market Segmentation
By formulation type the market for branded generics market is segmented into oral, parental, topical. By therapeutic application the branded generics market is segmented into oncology, cardiovascular, diabetes, neurology, gastrointestinal, dermatology, analgesics and anti-inflammatory.
On the basis of drug class the market is segmented into alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics, others. By category the market is segmented into simple generics, super generics, biosimilars.
On the basis of end-users the branded generics market is segmented into hospital, clinic, and ambulatory center.
On the basis of geography, branded generics market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Speak to Research Analyst for Further Query: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-branded-generics-market
Branded Generics Market Competitive Analysis:
The branded generics market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of branded generics market for global, Europe, North America, Asia Pacific and South America.
Branded Generics Market Major Market Competitors:
Some of the major players operating in branded generics market are Teva Pharmaceutical Industries Ltd., Novartis International AG., Mylan N.V., Abbott Healthcare Pvt Ltd., Actavis pharmaceuticals, Sun Pharmaceutical Industries Limited, Allergan, STADA Arzneimittel, Lupin Pharmaceuticals, Aspen Pharmacare Holding, Dr. Reddy's, Aurobindo, Cipla, Novartis AG, Pfizer , Eva Pharmaceutical Industries , Abbott Laboratories, Valeant Pharmaceuticals International among others
Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-branded-generics-market
Branded Generics Market Showing Global CAGR of 7.5% Upto 2024 with Companies Analysis Like Teva, Novartis, Mylan, Abbott, Actavis, Sun, Allergan, STADA and More
Global Branded Generics Market By Formulation Type (Oral, Parental, Topical), By Therapeutic Application (Oncology, Cardiovascular, Diabetes, Neurology, Gastrointestinal, Dermatology, Analgesics and Anti-inflammatory), By Category (Simple Generics, Super Generics, Biosimilars), By Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Others) By End User (Hospital, Clinic, Ambulatory Center), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa)